ListedSME platform

Pramodini Medicare Limited

PRAMODINI12 Aug 2026 – 14 Aug 2026
Issue price
₹118
final issue price
Issue size
—
Lot size
1,200 sh
₹1,41,600 a lot
Listed on
19 Aug 2026
NSE
Notes

Pramodini Medicare Limited was a SME-platform initial public offer.

The book was open from 12 August 2026 to 14 August 2026.

The issue was priced at ₹118 a share, from a band of ₹110 to ₹118.

As of the exchange's 14-Aug-2026 19:00:00 update the book was subscribed 0.00 times — bids came in below the number of shares on offer, counting bids on NSE and BSE together.

Against their reserved portions: qualified institutional buyers 0.00 times and non-institutional investors 0.00 times. Those portions add up to the whole offer; the sub-categories below each one are already counted inside it.

The shares listed on 19 August 2026.

How it has done since listing

This issue has no ISIN on file, so its listed price history cannot be matched.

The offer
Issue price
₹118
face value ₹10
Lot size
1,200 sh
₹1,41,600 a lot
Registrar
Purva Sharegistry (India) Private Limited
Lead manager
  • Smart Horizon Capital Advisors Private Limited
What happens when
3-day book
  1. Bidding opens12 Aug 2026
  2. Bidding closes14 Aug 2026
  3. Basis of allotmentnot published

    Not published in the exchange feeds we ingest — we do not estimate it.

  4. Listing19 Aug 2026
How the bidding is going
as of 14-Aug-2026 19:00:00
0.00x
NSE + BSE combined
93.78 L bid against 0 offered
captured 15 Aug 2026, 7:00 pm IST

Investors have bid for 0.00 times the shares on offer. Each category below has its own reserved portion, and those portions add up to the whole offer.

Institutional buyers (QIB)0.00x
42,82,800 bid · 0 offered
Non-institutional (HNI)0.00x
50,95,200 bid · 0 offered
NSE bids only — a different figure—

Bids placed on NSE alone, excluding BSE. It is smaller than the 0.00x headline above and the two must never be compared or added together.

Where in the price band the bids sit
as of 14 Aug 2026, 7:00 pm IST

Every bid names a price, or accepts whatever the final price turns out to be. This shows how many shares have been bid for at each price or above it — so the bar at the top of the band counts only the bids willing to pay it.

₹110
₹111
₹112
₹113
₹114
₹115
₹116
₹118

The columns are near-identical because they are: demand falls only 0.68% between ₹110 and ₹118, so almost every bid was willing to pay the top of the band. The axis starts at zero — the flatness is the finding, not a missing scale.

Bid at cut-off (no price named)
—

These accept whatever price the issue is finally set at, so they have no place on the price axis and are not in the chart.

Drop from ₹110 to ₹118
0.68%

How much of the demand falls away between the bottom and the top of the band.

Cumulative shares bid at or above each price in the band, from the exchange's own demand schedule. Bids placed at cut-off carry no price and are counted separately.

Anchor investors

We have not extracted an anchor allotment list for this issue.

When locked shares come free
computed from ICDR rules
  • Anchor investors — first tranche
    SEBI ICDR 2018 Reg. 32(5)(b) — 50% of the anchor allocation, 30 days from allotment
    18 Sept 2026
    50% of this tranche
  • Anchor investors — second tranche
    SEBI ICDR 2018 Reg. 32(5)(a) — the remaining 50% of the anchor allocation, 90 days from allotment
    17 Nov 2026
    50% of this tranche
  • All other pre-issue capital
    SEBI ICDR 2018 Reg. 17 — all other pre-issue capital, 6 months from allotment
    19 Feb 2027
    whole tranche releases on this date
  • Promoters' minimum contribution
    SEBI ICDR 2018 Reg. 16(1)(a) — promoters' minimum contribution, 18 months from allotment
    19 Feb 2028
    whole tranche releases on this date

Computed from the SEBI ICDR 2018 lock-in rules, not disclosed by the issuer or the exchange. The regulation counts from the date of allotment, which no feed we ingest publishes, so these are counted from the listing date and fall at most two to three business days later than the true expiry.

How the price was set

The "Basis for Offer Price" chapter states the earnings the price was set against and the multiples it implies. We have not extracted it for this issue — several offer documents are served as .zip archives or as scanned pages with no text layer.

Restated financials

We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.

Objects of the offer

We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.

Who the issuer compares itself to
as printed in the offer document

The offer document must name the listed companies the issuer considers comparable, and print their valuation figures beside its own. This is that list — the issuer’s choice of comparison, not ours.

CompanyP/ERoNW
Invicta Diagnostic Limited14.99.8%
Krsnaa Diagnostics Limited18.410.4%
Star Imaging & Path Labs Limitednot in our universe8.616.6%
The issuer’s own figures, as it printed them
EPS
₹10.41
NAV per share
₹31.84
Return on net worth
32.69%

The issuer's own figures as printed at the head of the same table — its claim about itself, on the same basis as its claims about the companies below.

Figures as PRINTED by the issuer in its own offer document. The comparison set is the issuer's choice, not ours.

Who ran this issue, and what else they have run
past issues only
Lead manager
FirmIssuesTypical listing move
Smart Horizon Capital Advisors Private Limited
2025 – 2026
6
1 measurable
+2.0%
Registrar
FirmIssuesTypical listing move
Purva Sharegistry India Pvt Limited
2022 – 2026
26
2 measurable
+10.2%

A count of what happened to the other issues each firm was named on, computed from exchange closes. Not a rating, not a ranking, and not a view on the firm.

Read the offer documents
6 filed

Filed with SEBI and the exchanges by the issuer. These are the source for every figure on this page.

Compiled from NSE and SEBI offer documents and exchange feeds. A description of the issue and of the bids received — not investment advice, and not a view on whether to apply. No grey-market premium, no allotment lookup and no listing-gain estimate is published here.